Falcon Point Capital’s Veracyte VCYT Stock Holding History

Falcon Point Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,948	Closed	-$258K	–	61
2020 Q2	$258K	Sell	9,948 -33,374	-77%	-$832K	1.26%	37
2020 Q1	$1.05M	Sell	43,322 -6,348	-13%	-$160K	2.28%	9
2019 Q4	$1.39M	Sell	49,670 -22,376	-31%	-$579K	1.77%	13
2019 Q3	$1.65M	Buy	72,046 +60,116	+504%	+$1.6M	0.91%	42
2019 Q2	$340K	Buy	+11,930	New	+$298K	0.18%	72

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Falcon Point Capital's VCYT Position: Q3 2020 in Review

Falcon Point Capital sold out of Veracyte (VCYT) in Q3 2020, closing a stake of 9,948 shares — an estimated $258K sold.

Falcon Point Capital first reported a position in VCYT in Q2 2019 and held it in 5 quarters. The position peaked at $1.65M in Q3 2019. 189 funds tracked by Wall St. Rank hold VCYT as of Q3 2020.

Falcon Point Capital reported no remaining Veracyte position as of Q3 2020 after selling out during the quarter.
Falcon Point Capital sold 9,948 Veracyte shares in Q3 2020, an estimated $258K.
Falcon Point Capital first reported a position in Veracyte in Q2 2019 and held it in 5 quarters.
Falcon Point Capital's Veracyte position peaked at $1.65M in Q3 2019.
189 funds tracked by Wall St. Rank held Veracyte as of Q3 2020.

Based on Falcon Point Capital's 13F filing for Q3 2020, filed 22 Oct 2020.